FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295774844> ?p ?o ?g. }

• W4295774844 endingPage "1932" @default.
• W4295774844 startingPage "1921" @default.
• W4295774844 abstract "Tricuspid regurgitation (TR) is prevalent and undertreated, with mortality and morbidity increasing with TR severity. Given poor outcomes with medical therapy and high in-hospital mortality for isolated tricuspid valve surgery, emerging transcatheter repair devices offer a promising alternative. The Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility study (NCT03382457) evaluates the treatment of functional TR via annular reduction with the Cardioband Tricuspid Valve Reconstruction System (Edwards Lifesciences). Patients with ≥ moderate functional TR were eligible for this prospective, single-arm multicenter study. At 1 year, patients were evaluated for echocardiographic parameters, clinical and quality-of-life measures, and major adverse events. The 37 patients enrolled had a mean age of 78 years; 76% were female; and they had ≥ severe functional (97.3%) or mixed (2.7%) TR, atrial flutter/fibrillation (97%), and New York Heart Association functional class III/IV (65%). At 1 year, 73.0% achieved ≤ moderate TR (P < 0.0001), and 73.1% had ≥2 grade reductions. Echocardiography showed significant reductions in the tricuspid annulus diameter (P < 0.0001), mean vena contracta (P < 0.0001), proximal isovelocity surface area effective regurgitant orifice area (P < 0.0001), right ventricular end-diastolic diameter (P < 0.0001), and inferior vena contracta (P = 0.0006). New York Heart Association functional class improved significantly (P < 0.0001), with 92.3% achieving class I/II, and Kansas City Cardiomyopathy Questionnaire scores improved by 19.0 points (P < 0.0001). One-year cardiovascular mortality was 8.1%, reinterventions were necessary in 5.4%, major access site complications occurred in 8.1%, and severe bleeding was noted in 35.1% of patients. Kaplan-Meier estimates of survival and freedom from heart failure rehospitalization were 85.9% and 88.7%, respectively. One-year experience using the Cardioband system for tricuspid valve repair shows high survival and low rehospitalization rates with durable outcomes in TR reduction and echocardiographic, clinical, and quality-of-life outcomes." @default.
• W4295774844 created "2022-09-15" @default.
• W4295774844 creator A5000044916 @default.
• W4295774844 creator A5003899849 @default.
• W4295774844 creator A5006250732 @default.
• W4295774844 creator A5017259364 @default.
• W4295774844 creator A5019475815 @default.
• W4295774844 creator A5021357839 @default.
• W4295774844 creator A5025956617 @default.
• W4295774844 creator A5032278660 @default.
• W4295774844 creator A5044601513 @default.
• W4295774844 creator A5055613208 @default.
• W4295774844 creator A5056375893 @default.
• W4295774844 creator A5063933561 @default.
• W4295774844 creator A5066854533 @default.
• W4295774844 creator A5070741151 @default.
• W4295774844 creator A5084185852 @default.
• W4295774844 creator A5085084670 @default.
• W4295774844 creator A5086494751 @default.
• W4295774844 creator A5091621842 @default.
• W4295774844 date "2022-10-01" @default.
• W4295774844 modified "2023-10-15" @default.
• W4295774844 title "1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study" @default.
• W4295774844 cites W1880802948 @default.
• W4295774844 cites W2003419166 @default.
• W4295774844 cites W2023688706 @default.
• W4295774844 cites W2081037869 @default.
• W4295774844 cites W2529400580 @default.
• W4295774844 cites W2735503437 @default.
• W4295774844 cites W2771350863 @default.
• W4295774844 cites W2775351706 @default.
• W4295774844 cites W2939812704 @default.
• W4295774844 cites W2946283324 @default.
• W4295774844 cites W2975059336 @default.
• W4295774844 cites W2987108929 @default.
• W4295774844 cites W3002405881 @default.
• W4295774844 cites W3089021322 @default.
• W4295774844 cites W3092322263 @default.
• W4295774844 cites W3102518094 @default.
• W4295774844 cites W3115258265 @default.
• W4295774844 cites W3117284102 @default.
• W4295774844 cites W3119361982 @default.
• W4295774844 cites W3161079474 @default.
• W4295774844 cites W3165158534 @default.
• W4295774844 cites W3186045370 @default.
• W4295774844 cites W4249896096 @default.
• W4295774844 doi "https://doi.org/10.1016/j.jcin.2022.07.006" @default.
• W4295774844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36202561" @default.
• W4295774844 hasPublicationYear "2022" @default.
• W4295774844 type Work @default.
• W4295774844 citedByCount "13" @default.
• W4295774844 countsByYear W42957748442022 @default.
• W4295774844 countsByYear W42957748442023 @default.
• W4295774844 crossrefType "journal-article" @default.
• W4295774844 hasAuthorship W4295774844A5000044916 @default.
• W4295774844 hasAuthorship W4295774844A5003899849 @default.
• W4295774844 hasAuthorship W4295774844A5006250732 @default.
• W4295774844 hasAuthorship W4295774844A5017259364 @default.
• W4295774844 hasAuthorship W4295774844A5019475815 @default.
• W4295774844 hasAuthorship W4295774844A5021357839 @default.
• W4295774844 hasAuthorship W4295774844A5025956617 @default.
• W4295774844 hasAuthorship W4295774844A5032278660 @default.
• W4295774844 hasAuthorship W4295774844A5044601513 @default.
• W4295774844 hasAuthorship W4295774844A5055613208 @default.
• W4295774844 hasAuthorship W4295774844A5056375893 @default.
• W4295774844 hasAuthorship W4295774844A5063933561 @default.
• W4295774844 hasAuthorship W4295774844A5066854533 @default.
• W4295774844 hasAuthorship W4295774844A5070741151 @default.
• W4295774844 hasAuthorship W4295774844A5084185852 @default.
• W4295774844 hasAuthorship W4295774844A5085084670 @default.
• W4295774844 hasAuthorship W4295774844A5086494751 @default.
• W4295774844 hasAuthorship W4295774844A5091621842 @default.
• W4295774844 hasBestOaLocation W42957748441 @default.
• W4295774844 hasConcept C126322002 @default.
• W4295774844 hasConcept C141071460 @default.
• W4295774844 hasConcept C164705383 @default.
• W4295774844 hasConcept C182536299 @default.
• W4295774844 hasConcept C2779161974 @default.
• W4295774844 hasConcept C2779946567 @default.
• W4295774844 hasConcept C2780168065 @default.
• W4295774844 hasConcept C71924100 @default.
• W4295774844 hasConceptScore W4295774844C126322002 @default.
• W4295774844 hasConceptScore W4295774844C141071460 @default.
• W4295774844 hasConceptScore W4295774844C164705383 @default.
• W4295774844 hasConceptScore W4295774844C182536299 @default.
• W4295774844 hasConceptScore W4295774844C2779161974 @default.
• W4295774844 hasConceptScore W4295774844C2779946567 @default.
• W4295774844 hasConceptScore W4295774844C2780168065 @default.
• W4295774844 hasConceptScore W4295774844C71924100 @default.
• W4295774844 hasFunder F4320306493 @default.
• W4295774844 hasFunder F4320307813 @default.
• W4295774844 hasFunder F4320309139 @default.
• W4295774844 hasIssue "19" @default.
• W4295774844 hasLocation W42957748441 @default.
• W4295774844 hasLocation W42957748442 @default.
• W4295774844 hasOpenAccess W4295774844 @default.
• W4295774844 hasPrimaryLocation W42957748441 @default.
• W4295774844 hasRelatedWork W2034606391 @default.

• next